Commerce Bank’s TG Therapeutics TGTX Stock Holding History

Commerce Bank’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	+4,428	New	+$181K	﹤0.01%	1232
2025 Q3	–	Sell	-7,393	Closed	-$266K	–	1251
2025 Q2	$266K	Sell	7,393 -1,700	-19%	-$63.3K	﹤0.01%	1077
2025 Q1	$359K	Buy	9,093 +2,304	+34%	+$77.5K	﹤0.01%	956
2024 Q4	$204K	Buy	+6,789	New	+$195K	﹤0.01%	1138
2021 Q2	–	Sell	-4,428	Closed	-$213K	–	1161
2021 Q1	$213K	Hold	4,428	–	–	﹤0.01%	1088
2020 Q4	$230K	Buy	+4,428	New	+$150K	﹤0.01%	1009

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Commerce Bank's TGTX Position: Q2 2026 in Review

Commerce Bank opened a new position in TG Therapeutics (TGTX) in Q2 2026: 4,428 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #1232 among its holdings. This is a return to the name: Commerce Bank previously reported a position in TGTX as recently as Q2 2025.

Commerce Bank first reported a position in TGTX in Q4 2020 and has held it in 6 quarters since. The position peaked at $359K in Q1 2025. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Commerce Bank held 4,428 shares of TG Therapeutics worth $243K as of Q2 2026.
TG Therapeutics was a new Commerce Bank position in Q2 2026.
TG Therapeutics made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #1232 holding.
Commerce Bank first reported a position in TG Therapeutics in Q4 2020 and has held it in 6 quarters since.
Commerce Bank's TG Therapeutics position peaked at $359K in Q1 2025.
428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.